These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11329057)

  • 1. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease.
    Delgado M; Abad C; Martinez C; Leceta J; Gomariz RP
    Nat Med; 2001 May; 7(5):563-8. PubMed ID: 11329057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
    Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
    Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the disease.
    Fernandez-Martin A; Gonzalez-Rey E; Chorny A; Martin J; Pozo D; Ganea D; Delgado M
    Ann N Y Acad Sci; 2006 Jul; 1070():276-81. PubMed ID: 16888178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.
    Delgado M; Abad C; Martinez C; Juarranz MG; Arranz A; Gomariz RP; Leceta J
    J Mol Med (Berl); 2002 Jan; 80(1):16-24. PubMed ID: 11862320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis.
    Gutiérrez-Cañas I; Juarranz Y; Santiago B; Martínez C; Gomariz RP; Pablos JL; Leceta J
    Brain Behav Immun; 2008 Mar; 22(3):312-7. PubMed ID: 17951026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.
    Juarranz Y; Abad C; Martinez C; Arranz A; Gutierrez-Cañas I; Rosignoli F; Gomariz RP; Leceta J
    Arthritis Res Ther; 2005; 7(5):R1034-45. PubMed ID: 16207319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells.
    Juarranz MG; Santiago B; Torroba M; Gutierrez-Cañas I; Palao G; Galindo M; Abad C; Martinez C; Leceta J; Pablos JL; Gomariz RP
    Rheumatology (Oxford); 2004 Apr; 43(4):416-22. PubMed ID: 14657510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E; Delgado M
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
    Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
    Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.
    Delgado M; Toscano MG; Benabdellah K; Cobo M; O'Valle F; Gonzalez-Rey E; Martín F
    Arthritis Rheum; 2008 Apr; 58(4):1026-37. PubMed ID: 18383372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells.
    Gonzalez-Rey E; Chorny A; O'Valle F; Delgado M
    Am J Pathol; 2007 Jan; 170(1):263-71. PubMed ID: 17200199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses.
    Gonzalez-Rey E; Chorny A; Del Moral RG; Varela N; Delgado M
    Ann Rheum Dis; 2007 May; 66(5):582-8. PubMed ID: 17151007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic effect of vasoactive intestinal peptide on experimental arthritis is associated with CD4+CD25+ T regulatory cells.
    Chen G; Hao J; Xi Y; Wang W; Wang Z; Li N; Li W
    Scand J Immunol; 2008 Dec; 68(6):572-8. PubMed ID: 19055696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA; Zhang Y; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.
    Leceta J; Gomariz RP; Martinez C; Carrión M; Arranz A; Juarranz Y
    Neuroimmunomodulation; 2007; 14(3-4):134-8. PubMed ID: 18073504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis.
    Deng S; Xi Y; Wang H; Hao J; Niu X; Li W; Tao Y; Chen G
    Cell Immunol; 2010; 265(2):105-10. PubMed ID: 20716449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M; Reduta A; Sharma V; Ganea D
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.